AlphaQuest LLC Grows Stock Holdings in Innospec Inc. $IOSP

AlphaQuest LLC boosted its stake in Innospec Inc. (NASDAQ:IOSP) by 56.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 45,174 shares of the specialty chemicals company’s stock after acquiring an additional 16,360 shares during the period. AlphaQuest LLC owned 0.18% of Innospec worth $3,486,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in shares of Innospec in the 2nd quarter valued at approximately $28,000. Versant Capital Management Inc lifted its holdings in shares of Innospec by 378.1% during the third quarter. Versant Capital Management Inc now owns 545 shares of the specialty chemicals company’s stock worth $42,000 after purchasing an additional 431 shares during the period. EverSource Wealth Advisors LLC grew its position in Innospec by 1,159.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock valued at $44,000 after buying an additional 487 shares during the last quarter. Blue Trust Inc. increased its stake in Innospec by 38.3% in the 2nd quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock valued at $57,000 after buying an additional 186 shares during the period. Finally, State of Wyoming increased its stake in Innospec by 27.5% in the 2nd quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock valued at $67,000 after buying an additional 173 shares during the period. 96.64% of the stock is owned by hedge funds and other institutional investors.

Innospec Stock Up 2.7%

Innospec stock opened at $81.41 on Friday. The firm has a market capitalization of $2.02 billion, a PE ratio of -2,713.67 and a beta of 0.91. Innospec Inc. has a 52 week low of $70.10 and a 52 week high of $116.95. The firm’s 50-day simple moving average is $77.82 and its 200 day simple moving average is $79.06.

Innospec (NASDAQ:IOSP) last posted its earnings results on Wednesday, November 5th. The specialty chemicals company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.09. Innospec had a negative net margin of 0.07% and a positive return on equity of 10.28%. The firm had revenue of $441.90 million during the quarter, compared to the consensus estimate of $443.00 million. During the same period last year, the firm posted $1.35 EPS. The firm’s revenue for the quarter was down .3% on a year-over-year basis. On average, research analysts expect that Innospec Inc. will post 6.18 EPS for the current fiscal year.

Innospec Dividend Announcement

The business also recently disclosed a dividend, which was paid on Wednesday, November 26th. Investors of record on Tuesday, November 18th were given a dividend of $0.87 per share. This represents a dividend yield of 245.0%. The ex-dividend date was Tuesday, November 18th. Innospec’s payout ratio is currently -5,800.00%.

Analysts Set New Price Targets

Several analysts have recently commented on IOSP shares. Zacks Research raised shares of Innospec from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 6th. Weiss Ratings reissued a “sell (d+)” rating on shares of Innospec in a report on Monday, December 22nd. Finally, Wall Street Zen raised Innospec from a “hold” rating to a “buy” rating in a report on Saturday, December 13th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Reduce”.

Insider Transactions at Innospec

In related news, Director Leslie J. Parrette bought 340 shares of Innospec stock in a transaction that occurred on Friday, November 14th. The shares were purchased at an average price of $74.09 per share, with a total value of $25,190.60. Following the purchase, the director owned 5,837 shares in the company, valued at $432,463.33. This represents a 6.19% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.31% of the company’s stock.

Innospec Company Profile

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.